Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
The latest update is out from NeueHealth Inc ( (NEUE) ).
On May 29, 2025, NeueHealth, Inc. held its annual meeting of stockholders where several key decisions were made. The stockholders elected ten directors to serve until the 2026 annual meeting, ratified the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025, and approved the executive compensation for 2024 on a non-binding, advisory basis.
The most recent analyst rating on (NEUE) stock is a Hold with a $7.00 price target. To see the full list of analyst forecasts on NeueHealth Inc stock, see the NEUE Stock Forecast page.
Spark’s Take on NEUE Stock
According to Spark, TipRanks’ AI Analyst, NEUE is a Neutral.
NeueHealth Inc.’s overall stock score reflects significant financial struggles with ongoing losses and liquidity concerns, offset by positive technical indicators and a strong earnings call that highlighted consumer growth and strategic initiatives. The valuation remains weak due to negative earnings. The combination results in a moderate score, indicating mixed prospects.
To see Spark’s full report on NEUE stock, click here.
More about NeueHealth Inc
Average Trading Volume: 20,990
Technical Sentiment Signal: Sell
Current Market Cap: $61.16M
See more data about NEUE stock on TipRanks’ Stock Analysis page.